The global gabapentin market was estimated to be worth USD 2.5 billion in 2022, and a compound annual growth rate (CAGR) of 2.6% is anticipated over the course of the projected period. The market is expanding due to a number of factors, including rising seizure rates, an aging population, more government programs and easier access to products, rising disposable income, and increased investment in R&D.

The market is expanding due to rising neurological disease cases, more pain management applications, and increased healthcare professional knowledge of gabapentin's potential for treating neuropathic disorders and other conditions. The drug's clearance for a number of ailments encourages market growth even further.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/gabapentin-market

Growth Drivers

Rising disposable income, growing awareness of neurological illnesses, growing applications in pain management, and people's growing health consciousness are all major factors propelling the market's expansion. Growth in the area is being propelled by gabapentin's adaptability in effectively and efficiently treating a wide range of medical disorders.

The market is expanding due to the growing need for gabapentin in the treatment of migraines and anxiety disorders. This medication is being confidently prescribed by doctors and other health professionals to treat a variety of illnesses. The market for gabapentin is expanding at a substantial rate because to the rising incidence of cardiovascular disorders and seizures. Governments throughout the globe are spending a lot of money on research and development, which has greatly expanded this sector. The market is expanding because to the rising prevalence of seizures and neurological illnesses.

Segmentation

Product Type

·         Capsule

·         Tablet

Route of Administration

·         Oral

·         Parenteral

·         Intravenous

Application

·         Epilepsy

·         Neuropathic pain

·         Restless Legs

Mode of Purchase

·         Prescription

·         Retail

·         Over the counter

Distribution Channel

·         Hospitals

·         Retail Pharmacies

·         Online

Regional Outlook

·         Asia Pacific

·         North America

·         Europe

·         Latin America

·         Middle East and Asia Pacific

Key Players

·         Amagen Inc

·         Bristol Myers Squibb Co.

·         Erytech Pharma

·         Novartis AG

·         Pfizer Inc

·         Rare Disease Therapeutics Inc

·         Baxter

·         Aurobindo Pharma limited

·         Zydus Cadila Healthcare ltd

·         Hikma Pharmaceuticals Plc

·         Dr. Reddy’s laboratories ltd

·         Mylan N.V.

·         Torrent pharmaceuticals ltd

·         Eisai Company Limited

·         Kiddis Pharma

·         OBI Pharma

·         Celgene Corporation

·         Spectrum Pharmaceuticals

·         Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/gabapentin-market

About Us: -  

xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:                                           
Company Name:  xResearch
Contact Person:  James Lin
Email:  sales@xresearch.biz
Phone: +1 718-619-8140

Websites: https://www.xresearch.biz/